Faslodex 250 Mg Injection which is the trade name for Fulvestrant, is used for the treatment of hormone receptor-positive metastatic breast cancer found in postmenopausal women.
Detailed Description:
Therapeutic Usage: It is used to treat estrogen receptor positive metastatic breast cancer (cancer that has spread) in postmenopausal women, with disease progression following antiestrogen therapy
It is manufactured by AstraZeneca Pharmaceuticals
Faslodex 250 Mg Injection which is the trade name for Fulvestrant, is used for the treatment of hormone receptor-positive metastatic breast cancer found in postmenopausal women.
Detailed Description:
Drug type: Faslodex is a hormone therapy
It fights cancer as an estrogen receptor down-regulator
Therapeutic Usage: It is used to treat estrogen receptor positive metastatic breast cancer (cancer that has spread) in postmenopausal women, with disease progression following antiestrogen therapy
Additional Information:
Port of Dispatch: Mumbai
Production Capacity: 3000-4000
Delivery Time: 7-8 days
![]() |
3S CORPORATION
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |